公司资料
Achilles Therapeutics 股价、新闻与催化剂
- 股票代码:
- ACHL
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United Kingdom
股价为何变动
Current closing-price context is not available for ACHL.
公司概览
业务概览
Achilles Therapeutics was a T-cell and immunology company focused on precision cancer treatment before its restructuring and public-market decline. Its platform centered on clonal neoantigen targeting.
所在地与行业分类
Headquartered in the United Kingdom and listed on NASDAQ as an ADR before restructuring, Achilles sat in oncology biotechnology.
商业模式特征
The company depended on clinical validation, platform science, and the ability to translate T-cell biology into value.
生物医药行业定位
Achilles belongs to the historical cell-therapy and restructuring category rather than the current live set.
未来催化剂
- Achilles Therapeutics’s catalysts are its T-cell program and any update that clarifies whether the company can keep its solid-tumor platform alive. The stock still depends on human proof.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。